We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Expanded Steroid Control Launched at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 10 Aug 2015
Print article
Image: The SMx Serum Specialty Matrix Control Sample (Photo courtesy of UTAK).
Image: The SMx Serum Specialty Matrix Control Sample (Photo courtesy of UTAK).
Expanded Steroid Control has been launched that now contains nine analytes of interest at clinically relevant levels for mass spectrometry and separation science technology.

The nine analytes included in the specialty matrix are Corticosterone, Cortisol, Cortisone, Dehydroepiandrosterone (DHEA), Progesterone, 17α-Hydroxyprogesterone, Testosterone, with the addition of Androstenedione and 11 Deoxycortisol.

The Expanded Steroid Control is manufactured by UTAK (Valencia, CA, USA) within its proprietary SMx Serum Specialty Matrix. For use with any methodology, UTAK's stock and custom quality controls are handcrafted and sold to Clinical, Toxicology and Esoteric laboratories globally. UTAK's Expanded Steroid Control in SMx Serum, is offered in individual packs for Levels 1, 2, 3, 4 and a Negative Control. The International Organization for Standardization (ISO) accreditation guidelines note that independent third party quality controls should be used instead of, or in addition to, any control materials supplied by the reagent or instrument manufacturer. UTAK offers hundreds of stock and custom serum, whole blood, urine and oral fluids controls for use with any methodology, on any testing platform.

Jim Plutchak, CEO of UTAK, said, “Our goal is always to craft Quality Controls for Clinical and Esoteric laboratories that are as close to a human matrix as possible. Due to the issue of endogenous steroid levels in serum-based matrix products, we developed a Steroids Control in our SMx Specialty Matrix. The result is a third party control that esoteric laboratories can depend on for their laboratory developed tests.” Charles E. Pippenger, PhD, adjunct professor Department of Neurosciences, University of Vermont College of Medicine added, “Inter-laboratory comparison of results, made possible with a uniform control, allows labs to be confident that test results generated are accurate.”

The Expanded SMx Steroid Control was released at the 2015 American Association of Clinical Chemistry (AACC) Meeting & Clinical Lab Expo held July 26–30, in Atlanta (GA, USA).

Related Links:
UTAK
University of Vermont College of Medicine 
American Association of Clinical Chemistry


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.